Multiple Genetic Alterations Cause Frequent and Heterogeneous Human Histocompatibility Leukocyte Antigen Class I Loss in Cervical Cancer
Open Access
- 13 March 2000
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 191 (6) , 961-976
Abstract
The nature and frequency of human histocompatibility leukocyte antigen (HLA) class I loss mechanisms in primary cancers are largely unknown. We used flow cytometry and molecular analyses to concurrently assess allele-specific HLA phenotypes and genotypes in subpopulations from 30 freshly isolated cervical tumor cell suspensions. Tumor-associated HLA class I alterations were present in 90% of the lesions tested, comprising four altered pheno/genotype categories: (a) HLA-A or -B allelic loss (17%), mostly associated with gene mutations; (b) HLA haplotype loss, associated with loss of heterozygosity at 6p (50%). This category included cases with additional loss of a (third) HLA-A or -B allele due to mutation, as well as one case with an HLA class I–negative tumor cell subpopulation, caused by a β2-microglobulin gene mutation; (c) Total HLA class I antigen loss and retention of heterozygosity (ROH) at 6p (10%); and (d) B locus or HLA-A/B downregulation associated with ROH and/or allelic imbalance at 6p (10%). Normal HLA phenotypes and ROH at 6p were observed in 10% of the cases. One case could not be classified (3%). Altered HLA class I antigen expression occurs in most cervical cancers, is diverse, and is mainly caused by genetic changes. Combined with widespread tumor heterogeneity, these changes have profound implications for natural immunity and T cell–based immunotherapy in cervical cancer.Keywords
This publication has 61 references indexed in Scilit:
- Mutations of the β2‐microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptidesTissue Antigens, 1998
- beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.Journal of Clinical Investigation, 1998
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- ??2-Microglobulin gene mutations in human melanoma cellsMelanoma Research, 1997
- High frequency of altered HLA class I phenotypes in invasive breast carcinomasHuman Immunology, 1996
- Stable inheritance of an HLA‐“blank' phenotype associated with a structural mutation in the HLA‐A*0301 geneTissue Antigens, 1996
- Mechanisms of loss of HLA class I expression on colorectal tumor cellsTissue Antigens, 1996
- Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell lineTissue Antigens, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- The multistep nature of cancerTrends in Genetics, 1993